{
    "nctId": "NCT04342546",
    "briefTitle": "Predictive Toxicity Test Linked to Radiotherapy After Mastectomy and Immediate Implant Reconstruction",
    "officialTitle": "Prospective Evaluation of a Predictive Toxicity Test Post Radiotherapy After Mastectomy With Immediate Implant Reconstruction",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer, Capsular Contracture Associated With Breast Implant",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "OTHER",
    "enrollmentCount": 250,
    "primaryOutcomeMeasure": "Ability of a radiosensitivity test to predict capsular contracture",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age \u226518 years\n* Patients with histologically confirmed breast cancer with indication of mastectomy or surgery with mastectomy performed\n* Indication of wall chest radiation after mastectomy\n* Patient's agreement to receive or having had an immediate breast reconstruction by implant in one or two steps, with or without a dermal or synthetic matrix (depending on the habits of the center)\n* Performance Status 0-1\n* Consent signed before any study procedure\n* Patient geographically accessible for follow-up\n* Affiliated to the French national social security system\n\nExclusion Criteria:\n\n* Breast reconstruction with flap\n* Inflammatory breast cancer (cT4d)\n* Skin or parietal breast cancer (cT4 a, b or c)\n* Metastatic patients\n* Patients with bilateral breast cancer\n* History of homolateral breast cancer treated with radiotherapy\n* History of contralateral breast cancer\n* Pregnant or breastfeeding women\n* Legal incapacity or physical, psychological or mental status interfering with the patient's ability to sign the informed consent\n* Participation in an interventional clinical study or planned participation during study up to 12 months post-radiotherapy",
    "sex": "MALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}